Clinical Impact of Revised Cefepime Breakpoint in Patients with Enterobacteriaceae Bacteremia

Kap Sum Foong; Abigail L. Carlson; Satish Munigala; Carey Ann D. Burnham; David K. Warren

doi:10.1093/ofid/ofz341

Clinical Impact of Revised Cefepime Breakpoint in Patients with Enterobacteriaceae Bacteremia

Kap Sum Foong, Abigail L. Carlson, Satish Munigala, Carey Ann D. Burnham, David K. Warren

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The impact of the revised Clinical and Laboratory Standards Institute interpretative criteria for cefepime in Enterobacteriaceae remains unclear. We applied the new breakpoint on 644 previously defined cefepime-susceptible Enterobacteriaceae isolates. We found no differences in mortality or microbiological failure, regardless of isolates being susceptible or cefepime-susceptible dose-dependent by current criteria.

Original language	English
Article number	ofz341
Journal	Open Forum Infectious Diseases
Volume	6
Issue number	8
DOIs	https://doi.org/10.1093/ofid/ofz341
State	Published - Aug 1 2019

Keywords

bacteremia
cefepime
cefepime-susceptible dose-dependent
CLSI
Enterobacteriaceae
susceptibility

Access to Document

10.1093/ofid/ofz341

Fingerprint Dive into the research topics of 'Clinical Impact of Revised Cefepime Breakpoint in Patients with Enterobacteriaceae Bacteremia'. Together they form a unique fingerprint.

Cite this

@article{be41ff03ac954762a189547711d1b20d,

title = "Clinical Impact of Revised Cefepime Breakpoint in Patients with Enterobacteriaceae Bacteremia",

abstract = "The impact of the revised Clinical and Laboratory Standards Institute interpretative criteria for cefepime in Enterobacteriaceae remains unclear. We applied the new breakpoint on 644 previously defined cefepime-susceptible Enterobacteriaceae isolates. We found no differences in mortality or microbiological failure, regardless of isolates being susceptible or cefepime-susceptible dose-dependent by current criteria.",

keywords = "bacteremia, cefepime, cefepime-susceptible dose-dependent, CLSI, Enterobacteriaceae, susceptibility",

author = "Foong, {Kap Sum} and Carlson, {Abigail L.} and Satish Munigala and Burnham, {Carey Ann D.} and Warren, {David K.}",

year = "2019",

month = aug,

day = "1",

doi = "10.1093/ofid/ofz341",

language = "English",

volume = "6",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

number = "8",

}

TY - JOUR

T1 - Clinical Impact of Revised Cefepime Breakpoint in Patients with Enterobacteriaceae Bacteremia

AU - Foong, Kap Sum

AU - Carlson, Abigail L.

AU - Munigala, Satish

AU - Burnham, Carey Ann D.

AU - Warren, David K.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - The impact of the revised Clinical and Laboratory Standards Institute interpretative criteria for cefepime in Enterobacteriaceae remains unclear. We applied the new breakpoint on 644 previously defined cefepime-susceptible Enterobacteriaceae isolates. We found no differences in mortality or microbiological failure, regardless of isolates being susceptible or cefepime-susceptible dose-dependent by current criteria.

AB - The impact of the revised Clinical and Laboratory Standards Institute interpretative criteria for cefepime in Enterobacteriaceae remains unclear. We applied the new breakpoint on 644 previously defined cefepime-susceptible Enterobacteriaceae isolates. We found no differences in mortality or microbiological failure, regardless of isolates being susceptible or cefepime-susceptible dose-dependent by current criteria.

KW - bacteremia

KW - cefepime

KW - cefepime-susceptible dose-dependent

KW - CLSI

KW - Enterobacteriaceae

KW - susceptibility

UR - http://www.scopus.com/inward/record.url?scp=85084289488&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofz341

DO - 10.1093/ofid/ofz341

M3 - Article

C2 - 31660387

AN - SCOPUS:85084289488

VL - 6

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

SN - 2328-8957

IS - 8

M1 - ofz341

ER -